MX345764B - Métodos para preparar glicoesfingolípidos y usos de los mismos. - Google Patents
Métodos para preparar glicoesfingolípidos y usos de los mismos.Info
- Publication number
- MX345764B MX345764B MX2013007888A MX2013007888A MX345764B MX 345764 B MX345764 B MX 345764B MX 2013007888 A MX2013007888 A MX 2013007888A MX 2013007888 A MX2013007888 A MX 2013007888A MX 345764 B MX345764 B MX 345764B
- Authority
- MX
- Mexico
- Prior art keywords
- sub
- glycosphingolipids
- heteroaryl
- aryl
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
- C07H15/06—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical being a hydroxyalkyl group esterified by a fatty acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/18—Acyclic radicals, substituted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Crystallography & Structural Chemistry (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pyridine Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
La presente invención se refiere a métodos para la síntesis y preparación de alfa-glicoesfingolípidos. Se proporcionan métodos para la síntesis de a-galactosil ceramida, y análogos y variantes farmacéuticamente activos del mismo. Se proporcionan alfa-glicoesfingolípidos novedosos, en donde los compuestos son compuestos inmunogénicos los cuales sirven como ligandos para las células NKT (T asesinas naturales).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161430117P | 2011-01-05 | 2011-01-05 | |
PCT/US2012/020388 WO2012094540A2 (en) | 2011-01-05 | 2012-01-05 | Methods for preparation of glycosphingolipids and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2013007888A MX2013007888A (es) | 2014-09-11 |
MX345764B true MX345764B (es) | 2017-02-15 |
Family
ID=45688966
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2013007888A MX345764B (es) | 2011-01-05 | 2012-01-05 | Métodos para preparar glicoesfingolípidos y usos de los mismos. |
Country Status (15)
Country | Link |
---|---|
US (2) | US9181292B2 (es) |
EP (1) | EP2661440B1 (es) |
JP (2) | JP6057300B2 (es) |
KR (1) | KR102005003B1 (es) |
CN (1) | CN103748103A (es) |
AU (2) | AU2012204336C1 (es) |
BR (1) | BR112013017382B1 (es) |
CA (1) | CA2854725C (es) |
CO (1) | CO6761397A2 (es) |
ES (1) | ES2654382T3 (es) |
HK (1) | HK1197068A1 (es) |
IL (1) | IL227333B (es) |
MX (1) | MX345764B (es) |
RU (1) | RU2636587C2 (es) |
WO (1) | WO2012094540A2 (es) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7960139B2 (en) | 2007-03-23 | 2011-06-14 | Academia Sinica | Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells |
ES2442024T3 (es) | 2008-07-15 | 2014-02-07 | Academia Sinica | Matrices de glucano sobre portaobjetos de vidrio revestidos con aluminio de tipo PTFE y métodos relacionados |
US10087236B2 (en) | 2009-12-02 | 2018-10-02 | Academia Sinica | Methods for modifying human antibodies by glycan engineering |
US11377485B2 (en) | 2009-12-02 | 2022-07-05 | Academia Sinica | Methods for modifying human antibodies by glycan engineering |
WO2011130332A1 (en) | 2010-04-12 | 2011-10-20 | Academia Sinica | Glycan arrays for high throughput screening of viruses |
EP2975409B1 (en) | 2010-05-10 | 2018-10-31 | Academia Sinica | Zanamivir phosphonate congeners with anti-influenza activity and determining oseltamivir susceptibility of influenza viruses |
BR112013017382B1 (pt) | 2011-01-05 | 2021-03-16 | National Taiwan University | método de preparação de um composto de fórmula (5) |
WO2013119857A1 (en) | 2012-02-07 | 2013-08-15 | The Regents Of The University Of California | Glycosphingolipids for use in modulating immune responses |
US10130714B2 (en) | 2012-04-14 | 2018-11-20 | Academia Sinica | Enhanced anti-influenza agents conjugated with anti-inflammatory activity |
CA2880701A1 (en) | 2012-08-18 | 2014-02-27 | Academia Sinica | Cell-permeable probes for identification and imaging of sialidases |
EP2888238A4 (en) | 2012-08-21 | 2016-01-27 | Academia Sinica | BENZOCYCLOOCTYN COMPOUNDS AND USES THEREOF |
EP2727929A1 (en) * | 2012-10-30 | 2014-05-07 | Wittycell | Method of preparation of alpha galactosyl ceramides compounds |
US10086054B2 (en) | 2013-06-26 | 2018-10-02 | Academia Sinica | RM2 antigens and use thereof |
EP3013347B1 (en) | 2013-06-27 | 2019-12-11 | Academia Sinica | Glycan conjugates and use thereof |
CN105682666B (zh) * | 2013-09-06 | 2021-06-01 | 中央研究院 | 使用醣脂激活人类iNKT细胞 |
US10150818B2 (en) | 2014-01-16 | 2018-12-11 | Academia Sinica | Compositions and methods for treatment and detection of cancers |
WO2015109180A2 (en) | 2014-01-16 | 2015-07-23 | Academia Sinica | Compositions and methods for treatment and detection of cancers |
TWI797430B (zh) | 2014-03-27 | 2023-04-01 | 中央研究院 | 反應性標記化合物及其用途 |
CN106661099A (zh) | 2014-05-27 | 2017-05-10 | 中央研究院 | 抗her2醣抗体及其用途 |
WO2015184004A1 (en) | 2014-05-27 | 2015-12-03 | Academia Sinica | Anti-cd20 glycoantibodies and uses thereof |
TWI654202B (zh) | 2014-05-27 | 2019-03-21 | 中央研究院 | 增進抗體功效之通用糖型之組合物及方法 |
US10118969B2 (en) | 2014-05-27 | 2018-11-06 | Academia Sinica | Compositions and methods relating to universal glycoforms for enhanced antibody efficacy |
EP3154582A4 (en) | 2014-05-28 | 2018-01-10 | Academia Sinica | Anti-tnf-alpha glycoantibodies and uses thereof |
TWI745275B (zh) * | 2014-09-08 | 2021-11-11 | 中央研究院 | 使用醣脂激活人類iNKT細胞 |
US10495645B2 (en) | 2015-01-16 | 2019-12-03 | Academia Sinica | Cancer markers and methods of use thereof |
US9975965B2 (en) | 2015-01-16 | 2018-05-22 | Academia Sinica | Compositions and methods for treatment and detection of cancers |
EP3789766A1 (en) | 2015-01-24 | 2021-03-10 | Academia Sinica | Novel glycan conjugates and methods of use thereof |
WO2017083830A1 (en) * | 2015-11-13 | 2017-05-18 | La Jolla Institute For Allergy And Immunology | Sphingamide compounds and methods for binding inkt cells |
WO2017100457A1 (en) | 2015-12-11 | 2017-06-15 | Opko Diagnostics, Llc | Fluidic systems involving incubation samples and/or reagents |
JP6956719B2 (ja) | 2015-12-29 | 2021-11-02 | オプコ・ダイアグノスティクス・リミテッド・ライアビリティ・カンパニーOpko Diagnostics,Llc | 流体の収集のための物品 |
US10336784B2 (en) | 2016-03-08 | 2019-07-02 | Academia Sinica | Methods for modular synthesis of N-glycans and arrays thereof |
JP7213549B2 (ja) | 2016-08-22 | 2023-01-27 | シーエイチオー ファーマ インコーポレイテッド | 抗体、結合性断片、および使用の方法 |
DK3681512T3 (da) * | 2017-09-13 | 2021-09-06 | Abivax | ABX196 til anvendelse ved behandling af blærekræft |
EP3771948B1 (fr) | 2019-07-31 | 2025-03-19 | Omega SA | Cadran pour piece d`horlogerie |
CN110835361A (zh) * | 2019-10-21 | 2020-02-25 | 山东大学 | 一类唾液酸糖基给体及其制备方法和应用 |
WO2021142581A1 (zh) * | 2020-01-13 | 2021-07-22 | 郑州市御合源生物科技有限公司 | 一种糖苷化合物及其制备方法和应用 |
CN114805454B (zh) * | 2021-01-21 | 2023-07-18 | 中国科学院生态环境研究中心 | α-半乳糖神经酰胺类化合物及其制备方法和用途 |
CN117222414A (zh) | 2021-03-01 | 2023-12-12 | 脱落性治疗公司 | 用于激活恒定自然杀伤t-细胞的化合物和用于消除炎性衰老细胞的方法 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0676429B2 (ja) | 1987-03-09 | 1994-09-28 | 理化学研究所 | ラクト系列スフィンゴ糖脂質の合成法 |
JP2588729B2 (ja) * | 1987-10-05 | 1997-03-12 | 塩野義製薬株式会社 | スフィンゴシン誘導体 |
US5849716A (en) | 1992-10-22 | 1998-12-15 | Kirin Beer Kabushiki Kaisha | Sphingoglycolipids, their preparation, and therapeutic methods of use |
CA2142153A1 (en) * | 1994-03-04 | 1995-09-05 | Jacques Banville | Sulfated .beta.-glycolipid derivatives as cell adhesion inhibitors |
JPH11269189A (ja) * | 1998-03-19 | 1999-10-05 | Nissin Food Prod Co Ltd | 免疫調節作用を有する化合物 |
CN1405172A (zh) | 2001-08-13 | 2003-03-26 | 青岛海洋大学 | 一种乳糖胺脂及其制备方法和应用 |
DE10258007B4 (de) * | 2002-12-12 | 2006-02-09 | Sanofi-Aventis Deutschland Gmbh | Aromatische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel |
CN101036057A (zh) | 2004-10-04 | 2007-09-12 | 阿尔卡米亚有限公司 | 选择性抑制剂 |
US7923013B2 (en) * | 2004-12-28 | 2011-04-12 | The Rockefeller University | Glycolipids and analogues thereof as antigens for NKT cells |
WO2006071848A2 (en) | 2004-12-28 | 2006-07-06 | The Rockefeller University | Glycolipids and analogues thereof as antigens for nk t cells |
ES2689539T3 (es) * | 2006-04-03 | 2018-11-14 | Technion Research & Development Foundation Ltd. | Aminoglucósidos novedosos y usos de los mismos en el tratamiento de trastornos genéticos |
US8420607B2 (en) | 2006-06-30 | 2013-04-16 | University Of Georgia Research Foundation, Inc. | Anthrax carbohydrates, synthesis and uses thereof |
CN101012254A (zh) * | 2006-08-29 | 2007-08-08 | 中国海洋大学 | 一种α-半乳糖鞘糖脂的2’-OH衍生物及其制备方法 |
KR100868959B1 (ko) * | 2006-12-30 | 2008-11-17 | 재단법인서울대학교산학협력재단 | 알파-갈락토실세라마이드 유도체, 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는면역보조용 약학적 조성물 |
CA2683681A1 (en) | 2007-04-13 | 2008-10-23 | Academia Sinica | Alpha-galactosyl ceramide analogs and their use as immunotherapies |
US20090137793A1 (en) | 2007-11-19 | 2009-05-28 | Academia Sinica | Disaccharide compounds |
WO2009139719A1 (en) | 2008-05-16 | 2009-11-19 | Forskarpatent I Syd Ab | Novel synthesis of galactoside inhibitors |
US7928077B2 (en) | 2008-07-11 | 2011-04-19 | Academia Sinica | Alpha-galactosyl ceramide analogs and their use as immunotherapies |
BR112013017382B1 (pt) * | 2011-01-05 | 2021-03-16 | National Taiwan University | método de preparação de um composto de fórmula (5) |
-
2012
- 2012-01-05 BR BR112013017382-3A patent/BR112013017382B1/pt active IP Right Grant
- 2012-01-05 CN CN201280011839.4A patent/CN103748103A/zh active Pending
- 2012-01-05 JP JP2013548554A patent/JP6057300B2/ja active Active
- 2012-01-05 CA CA2854725A patent/CA2854725C/en active Active
- 2012-01-05 RU RU2013136531A patent/RU2636587C2/ru active
- 2012-01-05 EP EP12704939.3A patent/EP2661440B1/en active Active
- 2012-01-05 ES ES12704939.3T patent/ES2654382T3/es active Active
- 2012-01-05 MX MX2013007888A patent/MX345764B/es active IP Right Grant
- 2012-01-05 AU AU2012204336A patent/AU2012204336C1/en active Active
- 2012-01-05 KR KR1020137020635A patent/KR102005003B1/ko active IP Right Grant
- 2012-01-05 WO PCT/US2012/020388 patent/WO2012094540A2/en active Application Filing
- 2012-01-05 US US13/344,557 patent/US9181292B2/en active Active
-
2013
- 2013-07-04 IL IL227333A patent/IL227333B/en active IP Right Grant
- 2013-07-05 CO CO13159964A patent/CO6761397A2/es unknown
-
2014
- 2014-10-23 HK HK14110574.7A patent/HK1197068A1/xx unknown
-
2015
- 2015-10-07 US US14/877,897 patent/US10654880B2/en active Active
-
2016
- 2016-10-25 JP JP2016209071A patent/JP6259887B2/ja active Active
-
2017
- 2017-07-21 AU AU2017206277A patent/AU2017206277B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
HK1197068A1 (en) | 2015-01-02 |
IL227333A0 (en) | 2013-09-30 |
KR102005003B1 (ko) | 2019-07-29 |
AU2017206277A1 (en) | 2017-08-10 |
EP2661440B1 (en) | 2017-09-27 |
AU2017206277B2 (en) | 2019-05-02 |
BR112013017382B1 (pt) | 2021-03-16 |
CO6761397A2 (es) | 2013-09-30 |
RU2636587C2 (ru) | 2017-11-24 |
EP2661440A2 (en) | 2013-11-13 |
JP2017061481A (ja) | 2017-03-30 |
WO2012094540A3 (en) | 2012-08-30 |
WO2012094540A2 (en) | 2012-07-12 |
US10654880B2 (en) | 2020-05-19 |
JP6259887B2 (ja) | 2018-01-10 |
KR20140036147A (ko) | 2014-03-25 |
ES2654382T3 (es) | 2018-02-13 |
RU2013136531A (ru) | 2015-02-10 |
IL227333B (en) | 2018-01-31 |
AU2012204336B2 (en) | 2017-05-04 |
JP6057300B2 (ja) | 2017-01-11 |
US20160229881A1 (en) | 2016-08-11 |
JP2014504593A (ja) | 2014-02-24 |
MX2013007888A (es) | 2014-09-11 |
CA2854725C (en) | 2019-10-22 |
US9181292B2 (en) | 2015-11-10 |
US20120178705A1 (en) | 2012-07-12 |
BR112013017382A2 (pt) | 2016-10-04 |
AU2012204336A1 (en) | 2013-08-22 |
CN103748103A (zh) | 2014-04-23 |
CA2854725A1 (en) | 2013-07-12 |
AU2012204336C1 (en) | 2017-08-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX345764B (es) | Métodos para preparar glicoesfingolípidos y usos de los mismos. | |
ES2582471T3 (es) | Inhibidores polibásicos de la bomba de flujo de salida bacteriana que contienen boro y usos terapéuticos de los mismos | |
JO3098B1 (ar) | مركبات داي فينيل- بيرازول بيريدين وطريقة تحضيرها واستخدامها كمعدلات المستقبل النووي not | |
MY160745A (en) | A gasoline composition comprising one or more quaternary ammonium salt additives, and methods and uses thereto | |
RU2013134745A (ru) | Низкомолекулярные конъюгаты для внутриклеточной доставки нуклеиновых кислот | |
TW201204363A (en) | Certain amino-pyrimidines, compositions thereof, and methods for their use | |
MY156962A (en) | Fuel compositions | |
AR079226A1 (es) | Espiroindolinona- pirrolidinas, procesos de preparacion y uso de los mismos para el tratamiento y profilaxis del cancer | |
MD20140023A2 (ro) | Derivaţi de pirolpirimidină şi purină | |
MY169814A (en) | Diesel fuel compositions | |
MY149648A (en) | Carboxylalkylene-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament | |
GB0916848D0 (en) | Crystalline compound | |
EP2412700A4 (en) | METHOD FOR PRODUCING A BICYCLIC GAMMA AMINO ACID DERIVATIVE | |
NZ609874A (en) | Crystalline naloxol-peg conjugate | |
EA201291370A1 (ru) | Способ получения плеуромутилинов | |
MY171201A (en) | New carbamate glycolipid and use thereof | |
MY170076A (en) | Methods of treatment using lipid compounds | |
MX2014001282A (es) | Oxazolidinona que contiene compuestos de dimero, composicones y metodos para elaborar y usar. | |
GEP20125548B (en) | New dihidroindolone compounds, a process for its preparation and pharmaceutical compositions containing them | |
RU2013118021A (ru) | Способы и композиции для лечения сахарного диабета и дислипидемии | |
UY29485A1 (es) | Esteres alquílicos de aminoalcoholes cíclicos, composiciones farmacéuticas que los contienen, procedimientos de preparación y aplicaciones | |
CN104610359B (zh) | 一种制备磷酸特地唑胺的关键中间体及其制备方法 | |
MX2010001512A (es) | Nuevo procedimiento de preparacion. | |
AR075496A1 (es) | Proceso para la preparacion de compuestos opticamente activos usando hidrogenacion de transferencia y uso de los mismos | |
RU2014111983A (ru) | Стильбеноидные соединения в качестве ингибиторов плоскоклеточной карциномы и гепатомы и их применения |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |